NCT04545762 2026-01-14Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin LymphomaUniversity of California, San FranciscoPhase 1 Recruiting36 enrolled
NCT03117036 2025-05-21Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IIISamsung Medical CenterRecruiting600 enrolled